Ironwood Pharmaceuticals, Inc. (IRWD): Valuation
TTM figures as of June 30, 2026
Ironwood Pharmaceuticals, Inc. trades at 5.2 times trailing earnings and a 27.52% free-cash-flow yield. On P/E that is higher than 20% of its own month-end history back to 2010. The Healthcare median P/E is 22.9.
Earnings yield 19.26%.
138 month-end valuation observations are on file, starting December 2010.
Sector comparison uses 2682 Healthcare names.
Frequently asked questions
Is IRWD cheap versus its own history?
Ironwood Pharmaceuticals, Inc. trades at 5.2 times trailing earnings and a 27.52% free-cash-flow yield. On P/E that is higher than 20% of its own month-end history back to 2010. The Healthcare median P/E is 22.9.
What is IRWD's free-cash-flow yield?
Ironwood Pharmaceuticals, Inc. currently yields 27.52% of market cap as trailing free cash flow.
Where do these valuation figures come from?
Yields and quality metrics are computed from the same SEC TTM figures as the financials page, against the live market cap. Historical bands reconstruct month-end market cap from split-adjusted closes and the share count in the units it was filed, then divide by those dollar totals. Nothing here is a third-party estimate.